| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/23/1993 | EP0547558A1 Use of aminoguanidine for the manufacture of a medicament for inhibiting nitric oxide formation |
| 06/23/1993 | EP0547517A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation |
| 06/23/1993 | EP0547294A1 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
| 06/23/1993 | EP0547179A1 Triarylethylene carboxylic acids with estrogenic activity |
| 06/22/1993 | US5221678 Cardiovascular disorders, antiinflammatory agents, antiallergens |
| 06/21/1993 | CA2085819A1 Novel tricyclic steroid analogs |
| 06/19/1993 | CA2085456A1 17beta-n-substituted adamantyl/norbornanyl carbamoyl-4-aza-5a -androst -1-en-3-ones and adrostan-3-ones as 5a-reductase inhibitors |
| 06/17/1993 | CA2085399A1 Method for inhibiting nitric oxide formation |
| 06/16/1993 | EP0546547A1 Pharmaceutical composition for the improvement of dysuria |
| 06/16/1993 | CN1073174A Heterocyclic derivatives |
| 06/16/1993 | CN1073161A Endothelin receptor antagonists |
| 06/15/1993 | US5219886 Cardiovascular disorders, analgesics, enzyme inhibitors |
| 06/15/1993 | US5219854 Administering 3/2H/-pyridazinone compound |
| 06/11/1993 | CA2084962A1 Pharmaceutical composition for the improvement of dysuria |
| 06/10/1993 | WO1993011122A1 Piperazine derivatives as 5-ht1a antagonists |
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 06/10/1993 | WO1993010791A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | WO1993010781A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| 06/10/1993 | WO1993010779A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 06/10/1993 | CA2125149A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| 06/10/1993 | CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 06/10/1993 | CA2124445A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 06/09/1993 | EP0545095A1 1,3-Substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 06/08/1993 | US5217976 Hypotensive agents, congestive heart failure |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/02/1993 | CN1072601A Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 06/01/1993 | US5216024 Cell growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 06/01/1993 | CA1318682C Disubstituted benzylamines, their preparation process, their use medicine and their synthesising agents |
| 05/27/1993 | WO1993010113A1 Novel benzothiophene derivative |
| 05/27/1993 | WO1993010092A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 05/27/1993 | WO1993009800A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | WO1993009796A1 Use of interleukin-8 |
| 05/27/1993 | WO1993009793A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/27/1993 | WO1993009773A1 Preventive or curative for dysmenorrhea and food having function of preventing dysmenorrhea |
| 05/27/1993 | WO1992000067A3 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 05/27/1993 | CA2123709A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/27/1993 | CA2123418A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 05/27/1993 | CA2117285A1 Use of interleukin-8 |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
| 05/26/1993 | EP0543476A1 Use of interleukin-8 |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0373218B1 Kidney growth accelerator and process for its preparation |
| 05/26/1993 | CN1020899C Method for preparation of pyrrolidine derivatives |
| 05/25/1993 | US5214030 Urogenital disorders |
| 05/25/1993 | CA1318251C Combined use of an antigestagen and a progesterone systhesis inhibitor of the trilostane and epostane type |
| 05/19/1993 | EP0542554A1 Substituted N-biphenylyl lactams |
| 05/19/1993 | EP0542424A1 Oxytocin recepto and DNA coding for the same |
| 05/19/1993 | EP0541705A1 Substituted 1h-imidazol-5-yl]alkanoic acids |
| 05/18/1993 | US5212185 Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
| 05/18/1993 | US5212156 Srif-related peptides and uses thereof |
| 05/14/1993 | CA2082787A1 Substituted n-biphenylyl lactams |
| 05/13/1993 | WO1993009104A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008807A1 Phospholipid antimicrobial compositions |
| 05/13/1993 | WO1993008799A1 Endothelin receptor antagonists |
| 05/13/1993 | CA2122820A1 Endothelin receptor antagonists |
| 05/13/1993 | CA2122024A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | CA2118688A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 05/12/1993 | EP0540969A2 Derivatives of structurally modified VIP and pharmaceutical compositions containing them |
| 05/11/1993 | US5210086 Adrenergic antagonists, urogenital disorders |
| 05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
| 05/04/1993 | US5208246 Tetralones with pharmacological activity |
| 05/04/1993 | US5208243 Analgesics |
| 04/30/1993 | WO1993009087A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/30/1993 | CA2115847A1 Ethynyl alanine amino diol compounds for treatment of hypertension |
| 04/29/1993 | WO1993007889A1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 04/29/1993 | WO1993007833A1 Biocompatible implant for the timing of ovulation in mares |
| 04/28/1993 | EP0539336A1 Use of L-carnitine or of acyl L-carnitine for the treatment of idiopathic oligoasthenospermias |
| 04/28/1993 | EP0539154A1 Acridine-1,8-dione-derivatives as therapeutic agents |
| 04/28/1993 | EP0539153A1 Acridine derivative as therapeutic agent |
| 04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
| 04/28/1993 | EP0538367A1 Derivatives of pituitary posterior lobe hormones |
| 04/28/1993 | EP0538348A1 Process for producing unsaturated 17-alpha-cyanomethyl-17-beta-hydroxysteroids. |
| 04/28/1993 | EP0538342A1 Igf-1 and related compounds in pregnancy |
| 04/28/1993 | CN1071418A Benzo (f) quinolinones |
| 04/28/1993 | CN1071416A N-alkyl-3-phenyl-3-(2-alkylthiophe-noxy) propylamines |
| 04/27/1993 | US5206415 Modulation of gamma-aminobutyric acid receptor channel function |
| 04/27/1993 | CA1316928C Alpha-heterocycle substituted tolunitriles |
| 04/25/1993 | CA2081133A1 Pharmaceutical compounds |
| 04/22/1993 | CA2080950A1 Therapeutic agent |
| 04/22/1993 | CA2080949A1 Therapeutic agents |
| 04/21/1993 | EP0537915A1 N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors |
| 04/21/1993 | EP0407401B1 Human relaxin formulation |
| 04/20/1993 | US5204364 N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds |
| 04/20/1993 | US5204349 Treatment of preterm labor, dysmenorrhea and for stoppage of labor prior to cesarian delivery |
| 04/20/1993 | US5204346 Pyrazolopyridine compounds |
| 04/20/1993 | US5204340 Tetrahydrobenz(c,d)indole serotonin agonists |
| 04/15/1993 | WO1993007109A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 04/15/1993 | CA2120606A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phthalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 04/14/1993 | EP0536843A1 Antiandrogen-5-alpha-reductase inhibitor compositions and their preparation |
| 04/14/1993 | EP0536262A1 Substituted histidines |
| 04/13/1993 | US5202331 Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives |
| 04/13/1993 | US5202321 Antihistamine, antiallergens, antiinflammatory agents |
| 04/13/1993 | US5202314 10-thioethyl-steroids |
| 04/08/1993 | CA2078723A1 Win 49596-finasteride method of use and compositions |
| 04/07/1993 | EP0535925A1 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |